George H Conrades - Net Worth and Insider Trading

George H Conrades Net Worth

The estimated net worth of George H Conrades is at least $98 Million dollars as of 2024-12-27. George H Conrades is the Director of Akamai Technologies Inc and owns about 969,507 shares of Akamai Technologies Inc (AKAM) stock worth over $95 Million. George H Conrades is the Director of Oracle Corp and owns about 17,836 shares of Oracle Corp (ORCL) stock worth over $3 Million. George H Conrades is also the Director of Harley-Davidson Inc and owns about 0 shares of Harley-Davidson Inc (HOG) stock worth over $0. Details can be seen in George H Conrades's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George H Conrades has not made any transactions after 2024-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George H Conrades

To

George H Conrades Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George H Conrades owns 6 companies in total, including Cyclerion Therapeutics Inc (CYCN) , Oracle Corp (ORCL) , and Akamai Technologies Inc (AKAM) among others .

Click here to see the complete history of George H Conrades’s form 4 insider trades.

Insider Ownership Summary of George H Conrades

Ticker Comapny Transaction Date Type of Owner
CYCN Cyclerion Therapeutics Inc 2021-06-24 director
ORCL Oracle Corp 2024-05-03 director
AKAM Akamai Technologies Inc 2014-11-26 director & Executive Chairman
LIMIT LIMIT 2015-08-14 director
LIMIT LIMIT 2010-02-02 director
LIMIT LIMIT 2003-08-05 director

George H Conrades Latest Holdings Summary

George H Conrades currently owns a total of 3 stocks. Among these stocks, George H Conrades owns 969,507 shares of Akamai Technologies Inc (AKAM) as of November 26, 2014, with a value of $95 Million and a weighting of 96.88%. George H Conrades owns 17,836 shares of Oracle Corp (ORCL) as of May 3, 2024, with a value of $3 Million and a weighting of 3.12%. George H Conrades also owns 0 shares of Harley-Davidson Inc (HOG) as of August 14, 2015, with a value of $0 and a weighting of 0%.

Latest Holdings of George H Conrades

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKAM Akamai Technologies Inc 2014-11-26 969,507 97.96 94,972,906
ORCL Oracle Corp 2024-05-03 17,836 171.68 3,062,084
HOG Harley-Davidson Inc 2015-08-14 0 30.79 0

Holding Weightings of George H Conrades


George H Conrades Form 4 Trading Tracker

According to the SEC Form 4 filings, George H Conrades has made a total of 0 transactions in Akamai Technologies Inc (AKAM) over the past 5 years. The most-recent trade in Akamai Technologies Inc is the sale of 22,340 shares on November 26, 2014, which brought George H Conrades around $1 Million.

According to the SEC Form 4 filings, George H Conrades has made a total of 3 transactions in Oracle Corp (ORCL) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Oracle Corp is the sale of 20,000 shares on May 3, 2024, which brought George H Conrades around $2 Million.

According to the SEC Form 4 filings, George H Conrades has made a total of 0 transactions in Harley-Davidson Inc (HOG) over the past 5 years. The most-recent trade in Harley-Davidson Inc is the sale of 3,873 shares on August 14, 2015, which brought George H Conrades around $230,134.

Insider Trading History of George H Conrades

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George H Conrades Trading Performance

GuruFocus tracks the stock performance after each of George H Conrades's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George H Conrades is 14.18%. GuruFocus also compares George H Conrades's trading performance to market benchmark return within the same time period. The performance of stocks bought by George H Conrades within 3 months outperforms 7 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George H Conrades's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George H Conrades

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
7 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.96 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.35 LIMIT LIMIT LIMIT LIMIT LIMIT

George H Conrades Ownership Network

Ownership Network List of George H Conrades

No Data

Ownership Network Relation of George H Conrades

Insider Network Chart

George H Conrades Owned Company Details

What does Cyclerion Therapeutics Inc do?

Who are the key executives at Cyclerion Therapeutics Inc?

George H Conrades is the director of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include 10 percent owner Slate Path Capital Lp , Chief Scientific Officer Andreas Busch , and director & Chief Executive Officer Peter M Hecht .

Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary

Over the past 18 months, George H Conrades made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 357,880 shares made by Slate Path Capital Lp , and a net sale of 8 shares made by Terrance Mcguire .

In summary, during the past 3 months, insiders sold 357,880 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 357,880 shares. During the past 18 months, 357,888 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 357,888 shares.

Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclerion Therapeutics Inc Insider Transactions

No Available Data

George H Conrades Mailing Address

Above is the net worth, insider trading, and ownership report for George H Conrades. You might contact George H Conrades via mailing address: 500 Technology Square, Fifth Floor, Cambridge Ma 02139.

Discussions on George H Conrades

No discussions yet.